低CHA2DS2-VASc评分未抗凝房颤患者的代谢综合征与缺血性卒中
平均随访5.1年,MetS与缺血性卒中风险升高相关(aHR 1.19,95%CI 1.06-1.33,p=0.002),且代谢组分数量越多风险越高。
要点
- 在低CHA2DS2-VASc评分未抗凝房颤患者中,MetS与缺血性卒中风险增加独立相关。
- 代谢组分数量(4或5个)最多者卒中风险最高(aHR 1.38,95%CI 1.13-1.69)。
- 血压升高和腰围增加是独立关联的代谢组分,分别增加1.48倍和1.15倍风险。
核心结论
- 在CHA2DS2-VASc评分为0和1且未抗凝的房颤患者中,代谢综合征与缺血性卒中风险增加相关。
- 代谢负担与缺血性卒中风险呈线性增量关联,提示需要综合管理房颤患者的代谢异常。
研究设计与样本
- 根据房颤诊断前2年内健康体检数据定义的代谢综合征、代谢组分数量及单个代谢组分评估缺血性卒中风险。
主要发现
- 平均随访5.1年期间,1395例(1.84%)发生缺血性卒中。
- 代谢综合征与缺血性卒中风险升高相关(aHR 1.19,95%CI 1.06-1.33,p=0.002)。
- 代谢组分数量为4或5个者aHR最高为1.38(95%CI 1.13-1.69),而仅有单个组分者风险边缘(aHR 1.17,95%CI 0.97-1.40)。
- 血压升高和腰围增加分别与1.48倍和1.15倍缺血性卒中风险独立相关。
临床怎么用
- 对于CHA2DS2-VASc评分低(0或1)且未抗凝的房颤患者,应评估代谢综合征及其组分。
- 代谢负担越重,缺血性卒中风险越高,需综合管理代谢异常。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Conflicting results have been reported on whether metabolic syndrome (MetS) confers an increased risk of ischaemic stroke in atrial fibrillation (AF). We investigated the risk of ischaemic stroke according to MetS in patients with AF who are not indicated for oral anticoagulants. METHODS: A total of 76 015 oral anticoagulant-naïve patients with AF with low Congestive Heart Failure, Hypertension, Age ≥75 years (Doubled), Diabetes Mellitus, Stroke (Doubled), Vascular Disease, Age 65-74 years, Sex Category (Female) (CHA2DS2-VASc) score (0 and 1) were included from the National Health Information Database. The risk of ischaemic stroke was evaluated according to MetS, the number of MetS components (metabolic burden), and individual metabolic components defined by health examination data within 2 years of AF diagnosis. RESULTS: MetS was prevalent among 21 570 (28.4%) of the entire study population (mean age 49.8±11.1 years, mean CHA2DS2-VASc score 0.7±0.5). During a mean follow-up of 5.1 years, ischaemic stroke occurred in 1395 (1.84%) patients. MetS was associated with a higher risk of ischaemic stroke (adjusted HR (aHR) 1.19, 95% CI 1.06 to 1.33, p=0.002). Patients with the highest number of MetS components (4 or 5) showed the greatest aHR of 1.38 (95% CI 1.13 to 1.69), whereas those with a single component had a marginal risk of ischaemic stroke (aHR 1.17, 95% CI 0.97 to 1.40). Elevated blood pressure and increased waist circumference were independent components associated with 1.48-fold and 1.15-fold higher risks of ischaemic stroke, respectively. CONCLUSION: Among AF patients with CHA2DS2-VASc scores of 0 and 1 with no anticoagulation, MetS is associated with an increased risk of ischaemic stroke. Given the linear incremental association between metabolic burden and ischaemic stroke, the integrated management of metabolic derangements in AF is required.
引用
- Ahn, Lee, Choi, et al. Metabolic syndrome and ischaemic stroke in non-anticoagulated atrial fibrillation with low CHA2DS2-VASc scores. Heart. 2023. PMID: 36963818. doi:10.1136/heartjnl-2022-322143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。